In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Abgenix and Dyax to collaborate on novel antibody technology
Abgenix licenses antibody product candidates
Abgenix and Genentech Extend Antibody Technology Licensing Agreement
Abgenix to trial human monoclonal antibody in cancer patients
Lexicon delivers novel antigens to Abgenix
Abgenix and CuraGen agree development alliance
Chugai, CAT agree license deal
Antibody collaboration agreed by Abgenix and Immunex
Miikana Therapeutics and NovImmune sign alliance for antibody development